Jazz Pharmaceuticals PLC (JAZZ)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 4,068,950 | 3,834,200 | 3,659,370 | 3,094,240 | 2,363,570 |
| Property, plant and equipment | US$ in thousands | — | — | 301,376 | 343,423 | 127,935 |
| Fixed asset turnover | — | — | 12.14 | 9.01 | 18.47 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $4,068,950K ÷ $—K
= —
The fixed asset turnover ratio of Jazz Pharmaceuticals PLC has exhibited fluctuations over the years based on the provided data. In 2020, the ratio was notably high at 18.47, indicating that the company generated $18.47 in net sales for every dollar invested in fixed assets during that period.
However, there was a significant decrease in the fixed asset turnover ratio in 2021, dropping to 9.01. This decline suggests a decrease in the efficiency of utilizing fixed assets to generate sales revenue compared to the previous year.
The ratio rebounded in 2022 to 12.14, showing an improvement in utilizing fixed assets efficiently to generate sales. As for the subsequent years, the data is missing ('—'), and without this information, it is challenging to assess the ongoing trend in the company's fixed asset turnover.
Overall, the analysis of Jazz Pharmaceuticals PLC's fixed asset turnover ratio indicates fluctuations in the efficiency of generating sales revenue from fixed assets. It is advisable for stakeholders to further investigate the underlying reasons for these fluctuations to make informed decisions about the company's operational performance.
Peer comparison
Dec 31, 2024